Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
Mv0HrRhnLrhanHtc
